March 25, 2022 March 25, 2022Categories News StoriesEnrollment in TMIST breast cancer screening trial surpasses halfway mark; Black participation rises above 20%
March 17, 2022 March 17, 2022Categories News StoriesNCI-MATCH umbrella trial adds arm for LAG-3 expressing, mismatch repair deficient cancers
March 15, 2022 March 15, 2022Categories News StoriesThe results of the EA8141 phase II trial are part of mounting evidence showing the benefits of neoadjuvant chemotherapy
March 8, 2022 March 8, 2022Categories News StoriesJAMA Oncology publishes TAILORx data showing racial and neighborhood disparities in breast cancer
March 1, 2022 March 1, 2022Categories News StoriesFDA notes the NCI-MATCH trial in its release of new guidance on master protocols and expansion cohorts
February 28, 2022 February 28, 2022Categories News StoriesDr. Edith Mitchell discusses ECOG-ACRIN’s work to improve representation of minority populations in cancer clinical trials
February 28, 2022 February 28, 2022Categories News StoriesE1912 and other trials spur emergence of small molecule-inhibitor therapies for chronic lymphocytic leukemia
November 26, 2021 November 26, 2021Categories News StoriesTreatment sequence impacts survival in BRAF-mutant metastatic melanoma
November 12, 2021 November 12, 2021Categories News StoriesNCTN group chairs, experts: Diverse representation of minorities in clinical trials and drug development saves lives
